Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$27.38 - $42.21 $5,695 - $8,779
-208 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$26.34 - $46.62 $447 - $792
-17 Reduced 7.56%
208 $6,000
Q1 2021

May 12, 2021

BUY
$45.96 - $68.02 $3,217 - $4,761
70 Added 45.16%
225 $11,000
Q4 2020

Feb 10, 2021

BUY
$13.72 - $51.57 $2,126 - $7,993
155 New
155 $8,000
Q3 2020

Nov 13, 2020

SELL
$10.54 - $18.47 $249,545 - $437,295
-23,676 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$10.37 - $20.64 $123,413 - $245,636
-11,901 Reduced 33.45%
23,676 $431,000
Q1 2020

May 14, 2020

BUY
$9.63 - $17.14 $254,530 - $453,027
26,431 Added 288.99%
35,577 $431,000
Q4 2019

Feb 12, 2020

SELL
$7.2 - $13.2 $36,806 - $67,478
-5,112 Reduced 35.85%
9,146 $121,000
Q2 2019

Aug 09, 2019

BUY
$14.61 - $22.45 $208,309 - $320,092
14,258 New
14,258 $226,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.